Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,091 recruiting studies in this area right now.
By phase
- Not applicable4,197
- Phase 2597
- Phase 1409
- Phase 3325
- Phase 4251
- Phase 1/Phase 2246
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer337
- Cervical Cancer223
- Endometrial Cancer205
- Bladder Cancer187
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer110
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer77
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Kidney Cancer59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- AstraZeneca38
- University of Colorado, Denver38
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California350
- Alabama153
- Texas120
- Massachusetts118
- New York115
- Arizona106
- Florida102
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,091 total
- NCT07124312Recruiting
Placenta study for identical twin pregnancies
This trial studies the placentas of identical (monochorionic) twin pregnancies to learn more about their structure and health. Participation involves donating the placenta after birth for analysis.
Birmingham, West MidlandsAges Any age - NCT07122401RecruitingPhase 3
Study of MT1013 for dialysis patients with high parathyroid hormone
This trial tests a new medicine called MT1013 for people with secondary hyperparathyroidism who are on dialysis. It may help control high parathyroid hormone levels when current treatments are not enough.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07122414RecruitingPhase 1/Phase 2
Testing a new drug for bladder cancer that resists BCG
This trial tests a new drug (FL115) given directly into the bladder, alone or with BCG, for people with a type of bladder cancer that has not responded to BCG therapy. It aims to find a better treatment option for those who cannot have or refuse bladder removal surgery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07124000Recruiting
T-DXd for advanced HER2-positive solid tumors
This trial is for people with advanced HER2-positive solid tumors (cancers that cannot be removed by surgery or have spread). It tests the drug T-DXd (also called Enhertu) when your doctor has already decided it's the right treatment for you and you have no other good options.
Birmingham, AlabamaAges 18–130 - NCT07115745RecruitingPhase 1
Donor CAR T cells for severe autoimmune diseases
This study tests a new type of CAR T-cell therapy made from healthy donor cells. It is designed to help people with severe autoimmune diseases that have not improved with standard treatments.
Boston, MassachusettsAges 18 years+ - NCT06917950RecruitingPhase 1/Phase 2
Roxadustat for bone and brain health in dialysis patients
This study tests whether roxadustat, a medicine for anemia, can also help with bone problems and mood or thinking issues in people on hemodialysis.
Al Mansurah, DakahliyaAges 18 years+ - NCT07124260Recruiting
Gut and tongue bacteria study for low ovarian reserve
This study looks at the bacteria in your gut and on your tongue to see if they are different in women with low ovarian reserve. It may help doctors find new ways to understand and treat this condition.
Hangzhou, ZhejiangAges 20 years+ - NCT07121543Recruiting
Cervical cancer radiation side effect study
This study looks at how cervical cancer and radiation therapy affect the body. It aims to understand why side effects happen, which could lead to better treatment in the future.
La Jolla, CaliforniaAges 18 years+ - NCT07125547RecruitingPhase 2
Immunotherapy and chemo before surgery for ureteral cancer
This trial tests a combination of immunotherapy (tislelizumab) and chemotherapy (nab-paclitaxel) given before surgery for ureteral cancer. The goal is to see if the treatment shrinks the tumor and makes the surgery more effective.
Tianjin, Outside U.S.Ages 18 years+ - NCT07120529Recruiting
Comparing two types of hysterectomy for early cervical cancer
This study looks at two ways to remove the uterus and cervix for early-stage cervical cancer: minimally invasive surgery (like laparoscopic or robotic) versus open surgery (traditional large incision). It checks whether the less invasive approach works just as well in terms of survival and keeping the cancer from coming back.
BialystokAges 18–85 - NCT07124299RecruitingPhase 4
Alpha-blockers before kidney stone surgery: a randomized study
This trial tests whether taking an alpha-blocker medication before a type of kidney stone surgery (flexible ureteroscopy) helps the surgeon insert the ureteral access sheath more easily. Alpha-blockers are drugs that relax certain muscles, possibly making the procedure smoother and safer.
Santo André, São PauloAges 18 years+ - NCT07124702Recruiting
Quitting dual cigarette and e-cigarette use in pregnancy
This study tests a program to help pregnant people under 21 weeks who smoke both cigarettes and e-cigarettes. The goal is to help them quit both, focusing on those with lower household income.
Buffalo, New YorkAges 18 years+ - NCT07118683Recruiting
Brazilian health study for people with HIV or AIDS
This study is creating a record of chronic health conditions (like heart disease, diabetes, or high blood pressure) in people living with HIV or AIDS in Brazil. Joining helps researchers better understand and care for the health needs of people like you.
Goiânia, GoiásAges 18 years+ - NCT07115849Recruiting
Sex hormones and exercise response
This trial tests how different sex hormone levels affect the body's response to physical training. It may help explain why exercise works differently for different people.
Aarhus, JutlandAges 18–35 - NCT07117227Recruiting
Study to test a kidney cancer prediction model
This study is checking how well a model can predict the outcomes for people with kidney cancer who have had surgery. It looks at your medical records after surgery to help doctors better understand your recovery and future risks.
Beijing, Beijing MunicipalityAges 18–80 - NCT07119060Recruiting
Saving ovary tissue during endometrioma surgery
This study tests a surgical technique to remove ovarian cysts caused by endometriosis while preserving as much healthy ovary as possible. It is designed for women who want to preserve their fertility and plan to conceive after surgery.
BordeauxAges 18–43 - NCT07124390Recruiting
Electroacupuncture for stubborn overactive bladder
This study tests whether electroacupuncture (a type of acupuncture with mild electrical stimulation) can help women whose overactive bladder symptoms have not responded to usual treatments. If you join, you will receive electroacupuncture sessions and be monitored to see if your symptoms improve.
London, United KingdomAges 18 years+ - NCT07120971RecruitingEarly Phase 1
Metformin study for premature babies with lung disease
This study tests whether metformin, a medicine used for diabetes, can help premature babies with chronic lung disease (bronchopulmonary dysplasia, or BPD) breathe better. It may reduce the need for breathing machines.
Milwaukee, WisconsinAges 1 week–6 months - NCT07118813Recruiting
AI predicts kidney cancer surgery outcomes
This trial uses artificial intelligence to read CT scans and predict how well kidney cancer patients will do after surgery. It aims to help doctors plan better treatment for you.
Wuhan, HubeiAges 18 years+ - NCT07123298Recruiting
Program to help older adults feel less alone at home
This study tests a program called CAPABLE Care + Connect that helps older adults who feel lonely or isolated and have trouble with daily activities at home. It connects them with support to feel more capable and less alone.
Baltimore, MarylandAges 50 years+ - NCT07120958Enrolling by invitation
How uterine health affects embryo implantation
This trial studies how the immune system in the uterus may impact whether a genetically normal frozen embryo implants successfully. It aims to help improve success rates for women undergoing IVF.
Bisceglie, BTAges 20–42 - NCT07119424Recruiting
SGLT2 inhibitor study for older adults
This study looks at how a class of diabetes and kidney drugs called SGLT2 inhibitors affect older adults. It aims to understand the benefits for your kidneys and metabolism.
Milan, MilanAges 65 years+ - NCT07124871RecruitingPhase 2
PRP exosomes therapy for erectile dysfunction
This trial tests whether an injection of PRP exosomes can improve erectile dysfunction in men who have had some success with ED pills. It requires you to stop all other ED treatments for the study and attempt sex regularly.
ThessalonikiAges 40–70 - NCT07125391RecruitingPhase 2
Chemo plus propranolol before surgery for advanced ovarian cancer
This trial tests adding propranolol (a heart medication) to standard chemotherapy before surgery for advanced high-grade serous ovarian cancer. The goal is to see if this combination helps shrink tumors more effectively.
Hefei, AnhuiAges 18–75
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,091 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,865 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.